Dietary Sources of Lysophospholipids
Stopped early
Conditions studied: Obesity, Cardiovascular Risk Factor, Hyperlipidemia
In brief
This study aims to test the hypothesis that dietary intake of phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) acutely alters plasma lysophosphatidic acid (LPA) levels and autotaxin activity in normal weight and obese subjects.
Key facts
- Study ID
- NCT02952638
- Run by
- Susan Smyth
- People needed
- 44
- Starts
- 2015-07-14
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2021-07-21
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 to 60 years old
- Body Mass Index of 20 and above
- Must be able to consume a low fat meal, unlimited fruits and vegetables and not eating after midnight the night before the lipid tolerance test
- Report to the clinical research unit fasting (no food since the meal the night before)
- Able to consume a liquid meal consisting of a commercial nutritional product supplemented with fat
- Able to have an indwelling catheter placed on one arm and have hourly blood draws for 8 hours
You may not qualify if…
- Unstable medical condition (recent or unstable cardiovascular disease)
- Active cancer
- Renal insufficiency Glomerular Filtration Rate <30
- Use of steroids
- Chronic inflammatory conditions
- Use of anticoagulants, anti-inflammatory, or lipid-lowering medications
- Lipodystrophy
- GI conditions that result in lipid intolerance
- Pregnant women have a tendency to be anemic and therefore will be excluded.
Where it is running
- University of Kentucky Dept of Cardiology — Lexington, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.